Rumyana Markovska
Overview
Explore the profile of Rumyana Markovska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
465
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boyanova L, Gergova R, Markovska R
Anaerobe
. 2025 Feb;
92:102949.
PMID: 40010487
Coculture systems (CCSs) are experimental tools used to study the interactions of anaerobic bacteria among themselves and the gut epithelial cells under conditions simulating the human gut, unlike those in...
2.
Niyazi D, Vergiev S, Markovska R, Stoeva T
Antibiotics (Basel)
. 2024 Oct;
13(10).
PMID: 39452187
: Intestinal colonization by multidrug-resistant (MDR) bacteria is considered one of the main risk factors for invasive infections in the hematopoietic stem-cell transplant (HSCT) setting, associated with hard-to-eradicate microorganisms. The...
3.
Stankova P, Boyanova L, Atanasova D, Mihaylova S, Sredkova M, Gergova R, et al.
Microorganisms
. 2024 Sep;
12(9).
PMID: 39338452
The aim of the present work was to genetically characterise cefotaxime-resistant enterobacteria isolated from community carriers in Bulgaria. In total, 717 faecal samples from children and adults in five medical...
4.
Boyanova L, Boyanova L, Hadzhiyski P, Gergova R, Markovska R
Anaerobe
. 2024 Aug;
89:102897.
PMID: 39154706
Oxygen tolerance of anaerobes is a virulence factor, but can also be a beneficial property. Many species have evolved to tolerate or take advantage of the presence of low, especially...
5.
Markovska R, Stankova P, Popivanov G, Gergova I, Mihova K, Mutafchiyski V, et al.
Antibiotics (Basel)
. 2024 Jul;
13(7).
PMID: 39061359
The rapid spread of carbapenemase-producing strains has led to increased levels of resistance among Gram-negative bacteria, especially enterobacteria. The current study aimed to collect and genetically characterize the colistin- and...
6.
Boyanova L, Medeiros J, Yordanov D, Gergova R, Markovska R
Lett Appl Microbiol
. 2024 May;
77(6).
PMID: 38794899
Non-antibiotic adjuncts may improve Helicobacter pylori infection control. Our aim was to emphasize curcumin benefits in controlling H. pylori infection. We discussed publications in English mostly published since 2020 using...
7.
Popivanov G, Markovska R, Gergova I, Konaktchieva M, Cirocchi R, Kjossev K, et al.
Medicina (Kaunas)
. 2024 Mar;
60(3).
PMID: 38541237
appears to be a significant problem due to its ability to accumulate antibiotic-resistance genes. After 2013, alarming colistin resistance rates among carbapenem-resistant have been reported in the Balkans. The study...
8.
Markovska R, Stankova P, Stoeva T, Keuleyan E, Mihova K, Boyanova L
Antibiotics (Basel)
. 2024 Jan;
13(1).
PMID: 38247640
To solve the problem with pan-drug resistant and extensively drug-resistant Gram-negative microbes, newly approved drugs such as ceftazidime/avibactam, cefiderocol, plazomicin, meropenem/vaborbactam, and eravacycline have been introduced in practice. The aim...
9.
Boyanova L, Boyanova L, Hadzhiyski P, Kandilarov N, Yordanov D, Gergova R, et al.
Diagn Microbiol Infect Dis
. 2023 Sep;
107(4):116073.
PMID: 37717293
The aim of the study was to evaluate the frequency and characteristics of mixed (multiple-genotype) Helicobacter pylori infections (MGIs) in 155 Bulgarian symptomatic patients (21 children and 134 adults). MGIs...
10.
Boyanova L, Dimitrov G, Gergova R, Hadzhiyski P, Markovska R
Expert Rev Clin Pharmacol
. 2023 Aug;
16(10):925-938.
PMID: 37642560
Introduction: Updating data on antibiotic resistance is important for treatment improvement of infections (CDIs). Areas Covered: Results from 20 countries were included. The mean resistance to 2 mg/l vancomycin, 2 ...